Kira Schreiner Simonsen

Research activity per year

Fingerprint

Dive into the research topics where Kira Schreiner Simonsen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Journal article

Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLC
Andersen, R., Jespersen, M. S., Presti, M., Bjornhart, B., Østby, A. C., Darras, A. K. M., Garitaonaindia, Y., Ruhlmann, C. H., Frank, M. S., Schmidt, H., Friis, R. B., Guldbrandt, L. M., Henriksen, J. R., Bjerrum, A., Simonsen, K. S., Palshof, J. A., Borch, T. H., Andersen, J. L., Kjaer, S. & Jensen, N. V. & 16 others, Azimi, A., Iversen, A. B., Meldgaard, P., Steen, S. G., Khan, S., Luczak, A. A., Wahlstrøm, S., Zitnjak, D., Svane, I. M., Fristrup, N., Kristiansen, C., Persson, G. F., Bastholt, L., Poehl, M., Ellebaek, E. & Donia, M., 26 Jul 2026, In: European Journal of Cancer. 243, 116872.
Research output: Contribution to journal › Journal article › Research › peer-review

Kira Schreiner Simonsen

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLC

Kira Schreiner Simonsen

Fingerprint

Collaborations and top research areas from the last five years

Research output

Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLC